-+ 0.00%
-+ 0.00%
-+ 0.00%

Fractyl Health names Mike Zumdahl SVP of market access, commercial strategy

PUBT·06/01/2026 11:03:23
Listen to the news
Fractyl Health names Mike Zumdahl SVP of market access, commercial strategy
  • Fractyl Health named Mike Zumdahl senior vice president, market access and commercial strategy, ahead of REMAIN-1 topline data in early Q4 2026.
  • Zumdahl was vice president of global health economics, market access, government affairs at Inari Medical through its USD 4.9 billion sale to Stryker.
  • He previously led Commercial Access Partners, advising medtech firms on go-to-market strategy, health economics, reimbursement.
  • Earlier roles included nearly a decade at Novo Nordisk in national accounts, government payers, supporting GLP-1 health economics and value-based contracting.
  • Appointment comes as Fractyl targets a potential De Novo marketing application for Revita in late Q4 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fractyl Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606010700PRIMZONEFULLFEED9729326) on June 01, 2026, and is solely responsible for the information contained therein.